In 2016, Merck KGaA, Darmstadt, Germany posed a challenge to us following a global corporate rebrand: How could the company demonstrate its transformation into a vibrant science and technology company? The ‘Curiosity Initiative’ was born and served as the lever to articulate the company’s scientific and technological innovations in a global and differentiating way, ...
read more
The 28th of February marked Rare Disease Day—a global event where hundreds of patient organizations work to raise awareness of rare disease. While, by definition, an individual rare disease affects a small number of people, when taken together, it is estimated that rare diseases affect 300-350 million people worldwide and almost 30 million in ...
read more
In November, the Government of Indonesia hosted the 5th Global Health Security Agenda (GHSA) Ministerial meeting, bringing together delegations from governments, multilateral organizations, NGOs and the private sector to discuss the progress achieved to-date in strengthening health security capacity since the start of the GHSA and chart the way forward for the next phase ...
read more
Last year, Rabin Martin President & CEO Jeff Sturchio presented to the Exploring Partnership Governance in Global Health workshop presented by the National Academies of Sciences and Medicines. As we near World AIDS Day, sharing his thoughtful insights on how the multi-sectoral African Comprehensive HIV/AIDS Partnership (ACHAP) between the Bostwana government and the private ...
read more
Rabin Martin is proud to be a part of the Omnicom family, a company that is committed to promoting responsible practices and making positive contributions to society around the globe. Our work was recently featured in Omnicom’s 2017 Corporate Responsibility report, showcasing how we work at the intersection of the private sector and unmet public health need to help our clients become leaders in health.
read more